Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Myomo (MYO) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to 34.86%.

  • Myomo's EBITDA Margin fell 244600.0% to 34.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.51%, marking a year-over-year increase of 47500.0%. This contributed to the annual value of 19.07% for FY2024, which is 237100.0% up from last year.
  • According to the latest figures from Q3 2025, Myomo's EBITDA Margin is 34.86%, which was down 244600.0% from 47.56% recorded in Q2 2025.
  • Myomo's EBITDA Margin's 5-year high stood at 2.03% during Q4 2024, with a 5-year trough of 125.51% in Q1 2021.
  • Its 5-year average for EBITDA Margin is 54.45%, with a median of 51.16% in 2023.
  • As far as peak fluctuations go, Myomo's EBITDA Margin surged by 2480300bps in 2021, and later tumbled by -327300bps in 2025.
  • Quarter analysis of 5 years shows Myomo's EBITDA Margin stood at 67.11% in 2021, then increased by 18bps to 55.16% in 2022, then grew by 7bps to 51.16% in 2023, then soared by 96bps to 2.03% in 2024, then crashed by -1615bps to 34.86% in 2025.
  • Its EBITDA Margin was 34.86% in Q3 2025, compared to 47.56% in Q2 2025 and 35.8% in Q1 2025.